Cargando…

Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition

BACKGROUND: The treatment of microbial infections is becoming increasingly challenging because of limited therapeutic options and the growing number of pathogenic strains that are resistant to current antibiotics. There is an urgent need to identify molecules with novel modes of action to facilitate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Haoxin, Cowie, Andrew, Johnson, John A., Webster, Duncan, Martyniuk, Christopher J., Gray, Christopher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981992/
https://www.ncbi.nlm.nih.gov/pubmed/27514659
http://dx.doi.org/10.1186/s12864-016-2949-y
_version_ 1782447689871392768
author Li, Haoxin
Cowie, Andrew
Johnson, John A.
Webster, Duncan
Martyniuk, Christopher J.
Gray, Christopher A.
author_facet Li, Haoxin
Cowie, Andrew
Johnson, John A.
Webster, Duncan
Martyniuk, Christopher J.
Gray, Christopher A.
author_sort Li, Haoxin
collection PubMed
description BACKGROUND: The treatment of microbial infections is becoming increasingly challenging because of limited therapeutic options and the growing number of pathogenic strains that are resistant to current antibiotics. There is an urgent need to identify molecules with novel modes of action to facilitate the development of new and more effective therapeutic agents. The anti-mycobacterial activity of the C17 diyne natural products falcarinol and panaxydol has been described previously; however, their mode of action remains largely undetermined in microbes. Gene expression profiling was therefore used to determine the transcriptomic response of Mycobacterium smegmatis upon treatment with falcarinol and panaxydol to better characterize the mode of action of these C17 diynes. RESULTS: Our analyses identified 704 and 907 transcripts that were differentially expressed in M. smegmatis after treatment with falcarinol and panaxydol respectively. Principal component analysis suggested that the C17 diynes exhibit a mode of action that is distinct to commonly used antimycobacterial drugs. Functional enrichment analysis and pathway enrichment analysis revealed that cell processes such as ectoine biosynthesis and cyclopropane-fatty-acyl-phospholipid synthesis were responsive to falcarinol and panaxydol treatment at the transcriptome level in M. smegmatis. The modes of action of the two C17 diynes were also predicted through Prediction of Activity Spectra of Substances (PASS). Based upon convergence of these three independent analyses, we hypothesize that the C17 diynes inhibit fatty acid biosynthesis, specifically phospholipid synthesis, in mycobacteria. CONCLUSION: Based on transcriptomic responses, it is suggested that the C17 diynes act differently than other anti-mycobacterial compounds in M. smegmatis, and do so by inhibiting phospholipid biosynthesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-016-2949-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4981992
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49819922016-08-13 Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition Li, Haoxin Cowie, Andrew Johnson, John A. Webster, Duncan Martyniuk, Christopher J. Gray, Christopher A. BMC Genomics Research Article BACKGROUND: The treatment of microbial infections is becoming increasingly challenging because of limited therapeutic options and the growing number of pathogenic strains that are resistant to current antibiotics. There is an urgent need to identify molecules with novel modes of action to facilitate the development of new and more effective therapeutic agents. The anti-mycobacterial activity of the C17 diyne natural products falcarinol and panaxydol has been described previously; however, their mode of action remains largely undetermined in microbes. Gene expression profiling was therefore used to determine the transcriptomic response of Mycobacterium smegmatis upon treatment with falcarinol and panaxydol to better characterize the mode of action of these C17 diynes. RESULTS: Our analyses identified 704 and 907 transcripts that were differentially expressed in M. smegmatis after treatment with falcarinol and panaxydol respectively. Principal component analysis suggested that the C17 diynes exhibit a mode of action that is distinct to commonly used antimycobacterial drugs. Functional enrichment analysis and pathway enrichment analysis revealed that cell processes such as ectoine biosynthesis and cyclopropane-fatty-acyl-phospholipid synthesis were responsive to falcarinol and panaxydol treatment at the transcriptome level in M. smegmatis. The modes of action of the two C17 diynes were also predicted through Prediction of Activity Spectra of Substances (PASS). Based upon convergence of these three independent analyses, we hypothesize that the C17 diynes inhibit fatty acid biosynthesis, specifically phospholipid synthesis, in mycobacteria. CONCLUSION: Based on transcriptomic responses, it is suggested that the C17 diynes act differently than other anti-mycobacterial compounds in M. smegmatis, and do so by inhibiting phospholipid biosynthesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-016-2949-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-11 /pmc/articles/PMC4981992/ /pubmed/27514659 http://dx.doi.org/10.1186/s12864-016-2949-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Haoxin
Cowie, Andrew
Johnson, John A.
Webster, Duncan
Martyniuk, Christopher J.
Gray, Christopher A.
Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition
title Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition
title_full Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition
title_fullStr Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition
title_full_unstemmed Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition
title_short Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition
title_sort determining the mode of action of anti-mycobacterial c17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981992/
https://www.ncbi.nlm.nih.gov/pubmed/27514659
http://dx.doi.org/10.1186/s12864-016-2949-y
work_keys_str_mv AT lihaoxin determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition
AT cowieandrew determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition
AT johnsonjohna determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition
AT websterduncan determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition
AT martyniukchristopherj determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition
AT graychristophera determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition